Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab

Introduction Hepatotoxicity is observed due to cyclin-dependent kinase (CDK4/6) inhibitors used to treat hormone receptor-positive metastatic breast cancer. However, it should not be ignored that denosumab may be hepatotoxic, although it is rare. Case Report A 73-year-old female patient with breast...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of oncology pharmacy practice 2023-09, Vol.29 (6), p.1494-1497
Hauptverfasser:	Bayram, Doğan, Aktürk Esen, Selin, Uçar, Gökhan, Köş, Fahriye Tuğba
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal glands Alanine transaminase Aspartate aminotransferase Biopsy Breast cancer Cyclin-dependent kinases Hepatitis Hepatotoxicity Kinases Liver Lymph nodes Metastases Metastasis Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!